Dr. Elise Desperito, Breast Imaging Director at Memorial Sloan Kettering Cancer Center, shares her expertise on breast density and its crucial impact on cancer screening. She discusses the new FDA rule requiring breast density disclosure, which empowers women to understand their health better. The conversation dives into the relationship between breast density and cancer risk, the importance of early detection, and the nuances of various screening options. Listeners gain insights into the emerging challenges in mammography and the need for personalized healthcare strategies.